Robert T. deGavre
Directeur/Membre du Conseil chez Cardeas Pharma Corp.
Profil
Robert T.
deGavre is currently a Director at Cardeas Pharma Corp.
Previously, he held positions as a Director at Corus Pharma, Inc., Cardiac Insight, Inc., Treasurer at Inco Ltd., Treasurer & Vice President at Squibb Corp., and Officer at the US Department of the Navy.
He completed his undergraduate degree at Princeton University.
Postes actifs de Robert T. deGavre
| Sociétés | Poste | Début |
|---|---|---|
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert T. deGavre
| Sociétés | Poste | Fin |
|---|---|---|
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - |
| US Department of the Navy (District of Columbia) | Corporate Officer/Principal | - |
Cardiac Insight, Inc.
 Cardiac Insight, Inc. Medical SpecialtiesHealth Technology Cardiac Insight, Inc. develops body worn sensing and computing technologies for applications in cardiology, respiratory, and other complex disease states. Its products inlcude Cardea SOLO and Cardea 20/20 ECG. The company was founded by Brad Harlow and David T. Linker in 2008 and is headquartered in Bellevue, WA. | Président | - |
Inco Ltd.
 Inco Ltd. Other Metals/MineralsNon-Energy Minerals Vale Inco Ltd. manufactures nickel materials for manufacturing stainless steel and batteries. It also mines and processes copper, gold, cobalt and platinum metals. The company also manufactures flakes and powders for use in catalysts, electronics and paints. Its mining and processing operations are in Canada, Indonesia and the UK. Vale Inco was founded in 1901 and is located in Toronto, Canada. | Treasurer | - |
| Squibb Corp. | Treasurer | - |
Formation de Robert T. deGavre
| Princeton University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Health Technology |
| Squibb Corp. | Health Technology |
Inco Ltd.
Inco Ltd. Other Metals/MineralsNon-Energy Minerals Vale Inco Ltd. manufactures nickel materials for manufacturing stainless steel and batteries. It also mines and processes copper, gold, cobalt and platinum metals. The company also manufactures flakes and powders for use in catalysts, electronics and paints. Its mining and processing operations are in Canada, Indonesia and the UK. Vale Inco was founded in 1901 and is located in Toronto, Canada. | Non-Energy Minerals |
Cardeas Pharma Corp.
Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Health Technology |
Cardiac Insight, Inc.
Cardiac Insight, Inc. Medical SpecialtiesHealth Technology Cardiac Insight, Inc. develops body worn sensing and computing technologies for applications in cardiology, respiratory, and other complex disease states. Its products inlcude Cardea SOLO and Cardea 20/20 ECG. The company was founded by Brad Harlow and David T. Linker in 2008 and is headquartered in Bellevue, WA. | Health Technology |
| US Department of the Navy (District of Columbia) | Government |
